Blackstone Group, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Blackstone Group, Inc.
Entyvio strong again for Japanese firm as it raises net profit forecast on lower tax costs. Meanwhile, 'Wave 1' pipeline projects are progressing, with simultaneous development in major markets a key goal.
Japanese major sheds further non-core assets as it continues to focus on innovation and pay down debt following the Shire acquisition.
Japanese major presses on with post-Shire divestments even after passing strategic target.
In a widely anticipated move, Takeda has confirmed the sale of its consumer healthcare business in Japan, to the US private equity group Blackstone.
- Other Names / Subsidiaries
- The Blackstone Group Inc
- The Blackstone Group L.P